Provided by Tiger Fintech (Singapore) Pte. Ltd.

OncoCyte Corporation

3.14
-0.0500-1.57%
Volume:13.51K
Turnover:41.66K
Market Cap:89.80M
PE:-0.94
High:3.17
Open:3.16
Low:3.00
Close:3.19
Loading ...

Oncocyte Is Maintained at Buy by Lake Street

Dow Jones
·
22 May

OncoCyte reports Medicare boosts reimbursement for GraftAssureCore

TIPRANKS
·
21 May

BRIEF-Oncocyte Corp Says New CMS Reimbursement Price Rate Of $2,753 Per Result For Graftassurecore Assay

Reuters
·
20 May

OncoCyte Corp - New CMS Reimbursement Price Rate of $2,753 per Result for Graftassurecore Assay

THOMSON REUTERS
·
20 May

OncoCyte Corporation Releases Transcript for Q1 2025 Earnings Call

Reuters
·
15 May

Oncocyte Price Target Maintained With a $4.25/Share by Needham

Dow Jones
·
13 May

OncoCyte Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

OncoCyte Q1 Adj. EPS $(0.19) Beats $(0.23) Estimate, Sales $2.32M Beat $154.50K Estimate

Benzinga
·
13 May

OncoCyte Reports Q1 2025 Results and Business Progress

THOMSON REUTERS
·
13 May

OncoCyte Corp: Plan to Rename Company in Q2

THOMSON REUTERS
·
13 May

OncoCyte Corp expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
10 May

BRIEF-Oncocyte Provides Positive Update On Clinical Trial ProgresS

Reuters
·
30 Apr

OncoCyte Provides Positive Update on Clinical Trial Progress

THOMSON REUTERS
·
30 Apr

Oncocyte Provides Positive Update on Clinical Trial Progress

GlobeNewswire
·
30 Apr

Oncocyte’s Proprietary Assay Demonstrates Long-Term Clinical Validity

GlobeNewswire
·
29 Apr

STAAR Surgical Announces Changes to Board of Directors

Business Wire
·
25 Apr

Oncocyte Price Target Maintained With a $4.25/Share by Needham

Dow Jones
·
08 Apr

Oncocyte Files Secondary Stock Shelf

MT Newswires Live
·
01 Apr

OncoCyte files to sell 10.61M shares of common stock for holders

TIPRANKS
·
01 Apr

Oncocyte Price Target Maintained With a $4.00/Share by Stephens & Co.

Dow Jones
·
25 Mar